Preview

User

Not a user? Register with this site Forgot your password?

Medical Visualization

Advanced search

Imaging of cervical cancer. Consensus of experts

https://doi.org/10.24835/1607-0763-1341

Abstract

The article offers the latest view on possibilities of diagnostic algorithm to identify cervical cancer (CC), one of the most incidental tumor of the woman’s reproductive system. The algorithm is described as a consensus of leading expert in imaging diagnostics, as well as oncogynecologysts, investigating diagnostic challenges and cervical cancer therapies. The article sets forth the principal trends in using imaging methods, their role and possibilities for staging CC, planning and assessing the efficacy of applied therapy, on-going surveillance over patients, who have undergone specialized anti-cancer treatment.

About the Authors

N. A. Rubtsova
P. Hertsen Moscow oncology research institute – Branch of National Medical Research Radiological Centre of the Ministry of Healthcare of the Russian Federation
Russian Federation

Natalia A. Rubtsova – Doct. of Sci. (Med.), Head of the department of radiation diagnostics

3, 2nd Botkinsky proezd, Moscow 125284


T. P. Berezovskaia
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation (A. Tsyb MRRC)
Russian Federation

Tatiana P. Berezovskaia – Doct. of Sci. (Med.), Professor, Head of the MRI department 

10, Zhukov str., Obninsk 249031, Kaluga region


V. G. Bychenko
Research Center for Obstetrics, Gynecology and Perinatology named by V.I. Kulakov of the Ministry of Healthcare of the Russian Federation
Russian Federation

Vladimir G. Bychenko – Cand. of Sci. (Med.), Head of radiation diagnostics department

4, Akademika Oparina str., Moscow 117997


E. A. Pavlovskaya
N.N. Petrov National Medical Research Center of Oncology
Russian Federation

Evgenya A. Pavlovskaya – Cand. of Sci. (Med.), Radiologist

68, Leningradskaya str., Pesochny, Saint- Petersburg 197758


A. E. Solopova
Research Center for Obstetrics, Gynecology and Perinatology named by V.I. Kulakov of the Ministry of Healthcare of the Russian Federation
Russian Federation

Alina E. Solopova – Doct. of Sci. (Med.), Senior Researcher of the radiation diagnostics department 

4, Akademika Oparina str., Moscow 117997


T. A. Agababyan
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation (A. Tsyb MRRC)
Russian Federation

Tatev A. Agababyan – Cand. of Sci. (Med.), Head of radiation diagnostics department 

10, Zhukov str., Obninsk 249031, Kaluga region


M. M. Khodzhibekova
P. Hertsen Moscow oncology research institute – Branch of National Medical Research Radiological Centre of the Ministry of Healthcare of the Russian Federation
Russian Federation

Malika M. Khodzhibekova – Doct. of Sci. (Med.), Radiologist of the Radionuclide Diagnostics Department 

3, 2nd Botkinsky proezd, Moscow 125284


D. V. Ryzhkova
Almazov National Medical Research Centre
Russian Federation

Daria V. Ryzhkova – Doct. of Sci. (Med.), Professor, Chief Researcher of research department of nuclear medicine and theranostics of the institute of oncology and hematology, Head of the scientific and clinical association of nuclear medicine, head of the department of nuclear medicine and radiation technologies with the clinic of the institute of medical education of the Almazov Center

2, Akkuratova str., Saint-Petersburg 197341


M. A. Chekalova
Federal Scientific and Clinical Center for Special Types of Medical Care and Medical Technologies the Federal Medical Biological Agency (FMBA of Russia)
Russian Federation

Marina A. Chekalova – Doct. of Sci. (Med.), Professor, doctor of ultrasonic diagnostics of Federal Scientific and Clinical Center for Special Types of Medical Care and Medical Technologies The Federal Medical Biological Agency (FMBA of Russia); Professor, The Peoples' Friendship University of Russia

30, Volokolamskoye shosse, Moscow 125310


I. E. Meshkova
N.N. Petrov National Medical Research Center of Oncology
Russian Federation

Irina E. Meshkova – Cand. of Sci. (Med.), ultrasound diagnostic doctor, gynecological oncologist

68, Leningradskaya str., Pesochny, Saint- Petersburg 197758


V. E. Gazhonova
Central State Medical Academy Administration of the President of the Russian Federation
Russian Federation

Veronica E. Gazhonova – Doct. of Sci. (Med.), Professor, Head of the ultrasound angiography room, ultrasound diagnostics doctor 

19, bld. 1А, Marshal Timoshenko str., Moscow 121359


A. I. Gus
Research Center for Obstetrics, Gynecology and Perinatology named by V.I. Kulakov of the Ministry of Healthcare of the Russian Federation
Russian Federation

Alexandr I. Gus – Doct. of Sci. (Med.), Professor, Chief Researcher of department of ultrasound and functional diagnostics, visual diagnostics department 

4, Akademika Oparina str., Moscow 117997


S. S. Bagnenko
N.N. Petrov National Medical Research Center of Oncology
Russian Federation

Sergey S. Bagnenko – Doct. of Sci. (Med.), associate Professor, Head of the scientific department, Leading Researcher of the scientific department of diagnostic and interventional radiology

68, Leningradskaya str., Pesochny, Saint- Petersburg 197758


B. M. Medvedeva
Research Institute of Clinical and Experimental Radiology, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Healthcare of the Russian Federation
Russian Federation

Bela M. Medvedeva – Doct. of Sci. (Med.), Professor, Head of the department of X-ray diagnostics, Leading Researcher

23, Kashirskoe shosse, Moscow 115478


L. A. Ashrafyan
Research Center for Obstetrics, Gynecology and Perinatology named by V.I. Kulakov of the Ministry of Healthcare of the Russian Federation
Russian Federation

Levon A. Ashrafyan – Academician of the Russian Academy of Sciences, Doct. of Sci. (Med.), Professor, Deputy Director

4, Akademika Oparina str., Moscow 117997


E. G. Novikova
P. Hertsen Moscow oncology research institute – Branch of National Medical Research Radiological Centre of the Ministry of Healthcare of the Russian Federation
Russian Federation

Elena G. Novikova – Doct. of Sci. (Med.), Professor, Deputy Head of the Department of Tumors of the Reproductive and Urinary Organs

3, 2nd Botkinsky proezd, Moscow 125284


I. V. Berlev
N.N. Petrov National Medical Research Center of Oncology
Russian Federation

Igor V. Berlev – Doct. of Sci. (Med.), Professor, Head of the department of oncogynecology

68, Leningradskaya str., Pesochny, Saint- Petersburg 197758


L. V. Demidova
P. Hertsen Moscow oncology research institute – Branch of National Medical Research Radiological Centre of the Ministry of Healthcare of the Russian Federation
Russian Federation

Ludmila V. Demidova – Doct. of Sci. (Med.), Leading Researcher of the department of radiation therapy 

3, 2nd Botkinsky proezd, Moscow 125284


L. I. Krikunova
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation (A. Tsyb MRRC)
Russian Federation

Lyudmola I. Krikunova – Doct. of Sci. (Med.), Professor, Сhief scientific officer of the Department of Radiation and Combined Methods of Treatment of Gynecological Diseases with the Group of Restorative and Aesthetic Medicine

10, Zhukov str., Obninsk 249031, Kaluga region


L. A. Kolomiets
Research Institute of Oncology, Tomsk National medical research Center of the Russian Academy of Sciences
Russian Federation

Larisa A. Kolomiets – Doct. of Sci. (Med.), Professor, Head of the department of gynecology

5, Kooperativny per., Tomsk 634009


References

1. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynaecol. Obstet. 2009; 105 (2): 103–104. http://doi.org/10.1016/j.ijgo.2009.02.012

2. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the cervix uteri. Int. J. Gynaecol. Obstet. 2019; 145 (1): 129–135. http://doi.org/10.1002/ijgo.12749

3. Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Cancer of the cervix uteri. Int. J. Gynaecol. Obstet. 2018; 143 (Suppl. 2): 22–36. http://doi.org/10.1002/ijgo.12611

4. Berek J.S., Matsuo K., Grubbs B.H. et al. Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri. J. Gynecol. Oncol. 2019; 30 (2): e40. http://doi.org/10.3802/jgo.2019.30.e40

5. Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Corrigendum to “Revised FIGO staging for carcinoma of the cervix uteri”. Int. J. Gynecol. Obstet. 2019; 145: 129–135. http://doi.org/10.1002/ijgo.12969

6. Lee S.I., Atri M. 2018 FIGO staging system for uterine cervical cancer: enter cross-sectional imaging. Radiology. 2019; 292 (1): 15–24. http://doi.org/10.1148/radiol.2019190088

7. Olawaiye A.B., Baker T.P., Washington M.K., Mutch D.G. The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. CA Cancer J. Clin. 2021; 71 (4): 287–298. http://doi.org/10.3322/caac.21663

8. FIGO CANCER REPORT 2021 Cancer of the cervix uteri: 2021 update International Journal of Obstetrics and Gynaecology. 155 (S1). Special Issue: FIGO Cancer Report 2021 October: 28–44. https://doi.org/10.1002/ijgo.13967

9. Clinical guidelines approved by the scientific council of the Ministry of Health of the Russian Federation, Cervical Cancer, 2020, 48 p. (In Russian) https://oncology.ru/specialist/treatment/references/actual/537.pdf?ysclid=lp6m9w7k57670993368

10. Tian Y., Luo H. Diagnostic accuracy of transvaginal ultrasound examination for local staging of cervical cancer: a systematic review and meta-analysis. Med. Ultrason. 2022; 24 (3): 348–355. http://doi.org/10.11152/mu-3246

11. Cibula D., Pötter R., Planchamp F. et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Int. J. Gynecol. Cancer. 2018; 28 (4): 641–655. http://doi.org/10.1097/IGC.0000000000001216

12. Marth C., Landoni F., Mahner S. et al.; ESMO Guidelines Committee. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017; 28 (Suppl_4): iv72–iv83. http://doi.org/10.1093/annonc/mdx220

13. Chino J., Annunziata C.M., Beriwal S. et al. Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract. Radiat. Oncol. 2020; 10 (4): 220–234. http://doi.org/10.1016/j.prro.2020.04.002

14. Hricak H., Gatsonis C., Chi D.S. et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J. Clin. Oncol. 2005; 23 (36): 9329–9337. http://doi.org/10.1200/JCO.2005.02.0354

15. Xiao M., Yan B., Li Y. et al. Diagnostic performance of MR imaging in evaluating prognostic factors in patients with cervical cancer: a meta-analysis. Eur. Radiol. 2020; 30 (3): 1405–1418. http://doi.org/10.1007/s00330-019-06461-9

16. Thomeer M.G., Gerestein C., Spronk S. et al. Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma:systematic review and meta-analysis. Eur. Radiol. 2013; 23: 2005–2018. http://doi.org/10.1007/s00330-013-2783-4

17. Manganaro L., Lakhman Y., Bharwani N. et al. Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. Eur. Radiol. 2021; 31 (10): 7802–7816. http://doi.org/10.1007/s00330-020-07632-9. Erratum in: Eur. Radiol. 2021 Jun 17. PMID: 33852049

18. Bourgioti C., Chatoupis K., Moulopoulos L.A. Current imaging strategies for the evaluation of uterine cervical cancer. Wld J. Radiol. 2016; 8 (4): 342–354. http://doi.org/10.4329/wjr.v8.i4.342

19. Nogami Y., Iida M., Banno K. et al. Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects. Anticancer Res. 2014; 34 (2): 585–592. PMID: 24510987

20. Mirpour S., Mhlanga J., Logeswaran P. et al. The role of PET/CT in the management of cervical cancer. Am. J. Roentgenol. 2013; 201 (2): W192–205. http://doi.org/10.2214/AJR.12.9830

21. Choi H.J., Ju W., Myung S.K., Kim Y. Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci. 2010; 101 (6): 1471–1479. http://doi.org/10.1111/j.1349-7006.2010.01532.x

22. Liu B., Gao S., Li S. A comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography/ CT, and diffusion weighted imaging-MRI for detecting the lymph nodes metastases in patients with cervical cancer: a metaanalysis based on 67 studies. Gynecol. Obstet Invest. 2017; 82 (3): 209–222. http://doi.org/10.1159/000456006

23. Ruan J., Zhang Y., Ren H. Meta-analysis of PET/CT Detect Lymph Nodes Metastases of Cervical Cancer. Open Med. (Wars.) 2018; 13: 436–442. http://doi.org/10.1515/med-2018-0065

24. Young P., Daniel B., Sommer G. et al. Intravaginal gel for staging of female pelvic cancers–preliminary report of safety, distention, and gel-mucosal contrast during magnetic resonance examination. J. Comput. Assist. Tomogr. 2012; 36 (2): 253–256. http://doi.org/10.1097/RCT.0b013e3182483c05

25. Van Hoe L., Vanbeckevoort D., Oyen R. et al. Cervical carcinoma: optimized local staging with intravaginal contrast-enhanced MR imaging–preliminary results. Radiology. 1999; 213 (2): 608–611. http://doi.org/10.1148/radiology.213.2.r99oc23608

26. Akata D., Kerimoglu U., Hazirolan T. et al. Efficacy of transvaginal contrast-enhanced MRI in the early staging of cervical carcinoma. Eur. Radiol. 2005; 15 (8): 1727–1733. https://doi.org/10.1007/s00330-005-2645-9

27. Li X., Wang L., Li Y., Song P. The value of diffusionweighted imaging in combination with conventional magnetic resonance imaging for improving tumor detection for early cervical carcinoma treated with fertility-sparing surgery. Int. J. Gynecol. Cancer. 2017; 27 (8):1761–1768. http://doi.org/10.1097/IGC.0000000000001113

28. Woo S., Moon M.H., Cho J.Y. et al. Diagnostic performance of MRI for assessing parametrial invasion in cervical cancer: a head-to-head comparison between oblique and true axial T2-weighted images. Korean J. Radiol. 2019; 20 (3): 378–384. http://doi.org/10.3348/kjr.2018.0248

29. Hori M., Kim T., Onishi H. et al Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T-initial experience. Radiology. 2011; 258 (1): 154–163. http://doi.org/10.1148/radiol.10100866

30. Hwang J., Hong S.S., Kim H.J. et al. Reduced field-of-view diffusion-weighted MRI in patients with cervical cancer. Br. J. Radiol. 2018; 91 (1087): 20170864. http://doi.org/10.1259/bjr.20170864

31. Huang J.-W., Song J.-C., Chen T. et al. Making the invisible visible: improving detectability of MRI-invisible residual cervical cancer after conisation by DCE-MRI. Clin. Radiol. 2019; 74 (2): 166.e15–166.e21. http://doi.org/10.1016/j.crad.2018.10.013

32. Bermudez A., Bhatla N., Leung E. FIGO cancer report 2015. Cancer of the cervix uteri. Int. J. Gynecol. Obstet. 2015; 131: S88–95. http://doi.org/10.1016/j.ijgo.2015.06.004

33. Bentivegna E., Gouy S., Maulard A. et al. Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol. 2016; 17 (6): e240–e253. http://doi.org/10.1016/S1470-2045(16)30032-8

34. Zhang Q., Li W., Kanis M.J. et al. Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis. Oncotarget. 2017; 8 (28): 46580–46592. http://doi.org/10.18632/oncotarget.16233

35. Bentivegna E., Maulard A., Pautier P. et al. Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the Literature. Fertil Steril. 2016; 106 (5): 1195–1211.e5. https://doi.org/10.1016/j.fertnstert.2016.06.032

36. Koh W.J., Abu-Rustum N.R., Bean S. et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 2019; 17 (1): 64–84. http://doi.org/10.6004/jnccn.2019.0001

37. Engin G. Cervical cancer: MR imaging findings before, during, and after radiation therapy. Eur. Radiol. 2006; 16 (2): 313–324. http://doi.org/10.1007/s00330-005-2804-z

38. Hricak H., Yu K.K. Radiology in invasive cervical cancer. Am. J. Roentgenol. 1996; 167: 1101–1108. http://doi.org/10.2214/ajr.167.5.8911159

39. Lakhman Y., Akin O., Park K.J. et al. Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. Radiology. 2013; 269 (1): 149–158. https://doi.org/10.1148/radiol.13121746

40. Noël P., Dubé M., Plante M., St-Laurent G. Early cervical carcinoma and fertility-sparing treatment options: MR imaging as a tool in patient selection and a follow-upmodality. Radiographics. 2014; 34 (4): 1099–1119. https://doi.org/10.1148/rg.344130009

41. Downey K., Attygalle A.D., Morgan V.A. et al. Comparison of optimised endovaginal vs external array coil T2-weighted and diffusion-weighted imaging techniques for detecting suspected early stage (IA/IB1) uterine cervical cancer. Eur. Radiol. 2016; 26 (4): 941–950. http://doi.org/10.1007/s00330-015-3899-5

42. DeSouza N.M., Rockall A., Freeman S. Functional MR imaging in gynecologic cancer. Magn. Reson. Imaging Clin. N. Am. 2016; 24 (1): 205–222. http://doi.org/10.1016/j.mric.2015.08.008

43. Woo S., Suh C.H., Kim S.Y. et al. Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: an updated systematic review and meta-analysis of the literature between 2012 and 2016. Eur. Radiol. 2018; 28 (2): 530–541. http://doi.org/10.1007/s00330-017-4958-x

44. Park J.J., Kim C.K., Park S.Y., Park B.K. Parametrial invasion in cervical cancer: fused T2-weighted imaging and high-b-value diffusion-weighted imaging with background body signal suppression at 3 T. Radiology. 2015; 274 (3): 734–741. http://doi.org/10.1148/radiol.14140920

45. Sala E., Rockall A.G., Freeman S.J. et al. The Added Role of MR Imaging in Treatment Stratification of Patients with Gynecologic Malignancies: What the Radiologist Needs to Know. Radiology. 2013; 266: 717–740. http://doi.org/10.1148/radiol.12120315

46. Raithatha A., Papadopoulou I., Stewart V. et al. Cervical cancer staging: a resident’s primer: women’s imaging. Radiographics. 2016; 36 (3): 933–934. http://doi.org/10.1148/rg.2016150173

47. Eisenhauer E.A., Therasse P., Bogaerts J. et. al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer. 2009; 45 (2): 228–247. http://doi.org/10.1016/j.ejca.2008.10.026

48. Zhang A., Song J., Ma Z., Chen T. Application of apparent diffusion coefficient values derived from diffusion-weighted imaging for assessing different sized metastatic lymph nodes in cervical cancers. Acta Radiol. 2020; 61 (6): 848–855. https://doi.org/10.1177/0284185119879686

49. Qi Y.F., He Y.L., Lin C.Y. et al. Diffusion-weighted imaging of cervical cancer: Feasibility of ultra-high b-value at 3T. Eur. J. Radiol. 2020; 124: 108779. http://doi.org/10.1016/j.ejrad.2019.108779

50. Elsholtz F.H.J., Asbach P., Haas M. et al. Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer. Eur. Radiol. 2021; 31 (8): 6116–6124. https://doi.org/10.1007/s00330-020-07572-4

51. Wong T.Z., Jones E.L., Coleman R.E. Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. Mol. Imaging Biol. 2004; 6 (1): 55–62. http://doi.org/10.1016/j.mibio.2003.12.004

52. Hameeduddin A., Sahdev A. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies. Cancer Imaging. 2015; 15 (1): 3. http://doi.org/10.1186/s40644-015-0037-1

53. Young H., Baum R., Cremerius U. et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur. J. Cancer. 1999; 35 (13): 1773–1782. http://doi.org/10.1016/s0959-8049(99)00229-4

54. Wang X., Koch S. Positron emission tomography/ computed tomography potential pitfalls and artifacts. Curr. Probl. Diagn. Radiol. 2009; 38 (4): 156–169. http://doi.org/10.1067/j.cpradiol.2008.01.001

55. Amit A., Person O., Keidar Z. FDG PET/CT in monitoring response to treatment in gynecological malignancies. Curr. Opin. Obstet. Gynecol. 2013; 25 (1): 17–22. http://doi.org/10.1097/GCO.0b013e32835a7e96

56. American College of Radiology ACR Appropriateness Criteria: Pretreatment Planning of Invasive Cancer of the Cervix. https://acsearch.acr.org/docs/69461/Narrative/

57. Moore K.N., Herzog T.J., Lewin S. et al. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. Gynecol. Oncol. 2007; 105 (2): 299–303. http://doi.org/10.1016/j.ygyno.2006.12.031

58. Lorusso D., Petrelli F., Coinu A. et al. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol. Oncol. 2014; 133 (1): 117–123. http://doi.org/10.1016/j.ygyno.2014.01.042

59. Bodurka-Bevers D., Morris M., Eifel P.J. et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol. Oncol. 2000; 78 (2): 187–193. http://doi.org/10.1006/gyno.2000.5860.

60. Scottish Intercollegiate Guidelines Network. Management of cervical cancer/ (SIGN guideline no 99) 2008; National Comprehensive Cancer Network (NCCN) guidelines for cervical cancer/ 2022


Review

For citations:

Rubtsova N.A., Berezovskaia T.P., Bychenko V.G., Pavlovskaya E.A., Solopova A.E., Agababyan T.A., Khodzhibekova M.M., Ryzhkova D.V., Chekalova M.A., Meshkova I.E., Gazhonova V.E., Gus A.I., Bagnenko S.S., Medvedeva B.M., Ashrafyan L.A., Novikova E.G., Berlev I.V., Demidova L.V., Krikunova L.I., Kolomiets L.A. Imaging of cervical cancer. Consensus of experts. Medical Visualization. 2024;28(1):141-156. (In Russ.) https://doi.org/10.24835/1607-0763-1341

Views: 1082


ISSN 1607-0763 (Print)
ISSN 2408-9516 (Online)

Russia, 109004, Moscow, Stanislavsky St., 25
e-mail: karmazanovsky@ixv.ru   

Processing of personal data
supported by NEICON (Elpub lab)